Skip to main content

Advertisement

Log in

Impact of respiratory gating and ECG gating on 18F-FDG PET/CT for cardiac sarcoidosis

  • BRIEF REPORT
  • Published:
Journal of Nuclear Cardiology Aims and scope

Abstract

Background

The aim of this study was to estimate the impact of respiratory and electrocardiogram (ECG)-gated FDG positron emission tomography (PET)/computed tomography (CT) on the diagnosis of cardiac sarcoidosis (CS).

Methods and Results

Imaging from thirty-one patients was acquired on a PET/CT scanner equipped with a respiratory- and ECG-gating system. Non-gated PET images and three kinds of gated PET/CT images were created from identical list-mode clinical PET data: respiratory-gated PET during expiration (EX), ECG-gated PET at end diastole (ED), and ECG-gated PET at end systole (ES). The maximum standardized uptake value (SUVmax) and cardiac metabolic volume (CMV) were measured, and the locations of FDG accumulation were analyzed using a polar map. The mean SUVmax of the subjects was significantly higher after application of either respiratory-gated or ECG-gated reconstruction. Conversely, the mean CMV was significantly lower following the application of respiratory-gated or ECG-gated reconstruction. The segment showing maximum accumulation was shifted to the adjacent segment in 25.8%, 38.7%, and 41.9% of cases in EX, ED, and ES images, respectively.

Conclusion

In FDG PET/CT scanning for the diagnosis of CS, gated scanning is likely to increase quantitative accuracy, but the effect depends on the location and synchronization method.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

Abbreviations

CMV:

Cardiac metabolic volume

CS:

Cardiac sarcoidosis

FDG:

Fluorine-18-fluorodeoxyglucose

PET:

Positron emission tomography

SUVmax:

Maximum standardized uptake value

References

  1. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997;336:1224‐34.

    Article  CAS  PubMed  Google Scholar 

  2. Gilotra N, Okada D, Sharma A, Chrispin J. Management of Cardiac Sarcoidosis in 2020. Arrhythm Electrophysiol Rev 2020;9:182‐8.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Rathi VK, Biederman RW. Imaging of ventricular function by cardiovascular magnetic resonance. Curr Cardiol Rep 2004;6:55‐61.

    Article  PubMed  Google Scholar 

  4. Okune M, Yasuda M, Soejima N, Kagioka Y, Kakehi K, Kawamura T. Diagnostic utility of fusion (18)F-fluorodeoxyglucose positron emission tomography/cardiac magnetic resonance imaging in cardiac sarcoidosis. J Nucl Cardiol 2022;29:753‐64.

    Article  PubMed  Google Scholar 

  5. Livieratos L, Rajappan K, Stegger L, Schafers K, Bailey DL, Camici PG. Respiratory gating of cardiac PET data in list-mode acquisition. Eur J Nucl Med Mol Imaging 2006;33:584‐8.

    Article  PubMed  Google Scholar 

  6. Okuda K, Nakajima K. Has the era of dual-gated myocardial perfusion SPECT and PET arrived? J Nucl Cardiol 2020;27:648‐50.

    Article  PubMed  Google Scholar 

  7. Ishida Y, Yoshinaga K, Miyagawa M, Moroi M, Kondoh C, Kiso K, et al. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations. Ann Nucl Med 2014;28:393‐403.

    Article  PubMed  Google Scholar 

  8. Machac J, Bacharach SL, Bateman TM, Bax JJ, Beanlands R, Bengel F, et al. Positron emission tomography myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol 2006;13:e121‐51.

    Article  PubMed  Google Scholar 

  9. Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, et al. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis. Digest Version Circ J 2019;83:2329‐88.

    PubMed  Google Scholar 

  10. Langah R, Spicer K, Gebregziabher M, Gordon L. Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis. J Nucl Cardiol 2009;16:801‐10.

    Article  PubMed  Google Scholar 

  11. Watanabe S, Hanaoka K, Shibata Y, Kaida H, Ishii K. Usefulness of respiratory-gated 18F-FDG PET/CT scan protocol in patients having positive myocardial 18F-FDG uptake. Nucl Med Commun 2019;40:235‐41.

    Article  CAS  PubMed  Google Scholar 

  12. Manabe O, Kroenke M, Aikawa T, Murayama A, Naya M, Masuda A, et al. Volume-based glucose metabolic analysis of FDG PET/CT: The optimum threshold and conditions to suppress physiological myocardial uptake. J Nucl Cardiol 2019;26:909‐18.

    Article  PubMed  Google Scholar 

  13. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995;36:2138‐47.

    CAS  PubMed  Google Scholar 

  14. Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest 1993;103:253‐8.

    Article  CAS  PubMed  Google Scholar 

  15. Miller RJH, Cadet S, Pournazari P, Pope A, Kransdorf E, Hamilton MA, et al. Quantitative assessment of cardiac hypermetabolism and perfusion for diagnosis of cardiac sarcoidosis. J Nucl Cardiol 2022;29:86‐96.

    Article  PubMed  Google Scholar 

  16. Tahara N, Tahara A, Nitta Y, Kodama N, Mizoguchi M, Kaida H, et al. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. JACC Cardiovasc Imaging 2010;3:1219‐28.

    Article  PubMed  Google Scholar 

  17. Manabe O, Ohira H, Hirata K, Hayashi S, Naya M, Tsujino I, et al. Use of (18)F-FDG PET/CT texture analysis to diagnose cardiac sarcoidosis. Eur J Nucl Med Mol Imaging 2019;46:1240‐7.

    Article  CAS  PubMed  Google Scholar 

  18. Keall PJ, Kini VR, Vedam SS, Mohan R. Motion adaptive X-ray therapy: A feasibility study. Phys Med Biol 2001;46:1‐10.

    Article  CAS  PubMed  Google Scholar 

  19. Kamel E, Hany TF, Burger C, Treyer V, Lonn AH, von Schulthess GK, et al. CT vs 68Ge attenuation correction in a combined PET/CT system: Evaluation of the effect of lowering the CT tube current. Eur J Nucl Med Mol Imaging 2002;29:346‐50.

    Article  CAS  PubMed  Google Scholar 

  20. Kovalski G, Keidar Z, Frenkel A, Sachs J, Attia S, Azhari H. Dual, “motion-frozen heart” combining respiration and contraction compensation in clinical myocardial perfusion SPECT imaging. J Nucl Cardiol 2009;16:396‐404.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Edanz (https://jp.edanz.com/ac) for editing a draft of this manuscript.

Disclosures

The authors Kohei Hanaoka PhD, Shota Watanabe PhD, Daisuke Morimoto-Ishikawa MS, Hayato Kaida MD, PhD, Takahiro Yamada PhD, Masakazu Yasuda MD, PhD, Yoshitaka Iwanaga MD, PhD, Gaku Nakazawa MD, PhD, and Kazunari Ishii MD, PhD declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kohei Hanaoka PhD.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The authors of this article have provided a PowerPoint file, available for download at SpringerLink, which summarizes the contents of the paper and is free for re-use at meetings and presentations. Search for the article DOI on SpringerLink.com.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PPTX 333 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hanaoka, K., Watanabe, S., Morimoto-Ishikawa, D. et al. Impact of respiratory gating and ECG gating on 18F-FDG PET/CT for cardiac sarcoidosis. J. Nucl. Cardiol. 30, 1879–1885 (2023). https://doi.org/10.1007/s12350-023-03236-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-023-03236-0

Keywords

Navigation